Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas

Against the background of modest successes in the development of new diagnostic and therapeutic tools to improve the survival of patients with glial brain tumors, early diagnosis of this pathology remains relevant. Endogenous noncoding miRNAs that regulate the expression of target mRNAs have become...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Yu. Gvaldin, N. A. Petrusenko, E. E. Rostorguev, S. N. Dimitriadi, S. E. Kavitskiy, N. N. Timoshkina
Format: Article
Language:Russian
Published: QUASAR, LLC 2024-06-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/989
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524338989203456
author D. Yu. Gvaldin
N. A. Petrusenko
E. E. Rostorguev
S. N. Dimitriadi
S. E. Kavitskiy
N. N. Timoshkina
author_facet D. Yu. Gvaldin
N. A. Petrusenko
E. E. Rostorguev
S. N. Dimitriadi
S. E. Kavitskiy
N. N. Timoshkina
author_sort D. Yu. Gvaldin
collection DOAJ
description Against the background of modest successes in the development of new diagnostic and therapeutic tools to improve the survival of patients with glial brain tumors, early diagnosis of this pathology remains relevant. Endogenous noncoding miRNAs that regulate the expression of target mRNAs have become attractive targets for the development of circulating biomarker-based assays, because sample acquisition does not require invasive sampling such as biopsy.Purpose of the study. To determine the levels of circulating microRNAs in the blood plasma of patients with glial tumors, meningiomas and apparently healthy donors, using high-output sequencing.Material and methods. 26 blood plasma samples were selected from the biobank data base of the National Medical Research Center for Oncology, and the total RNA was studied using the NGS sequencing method. The sample included: 2 cases of oligodendroglioma (grades 2–3), 6 – astrocytomas of 2–4 degrees of malignancy, 7 – glioblastomas of 4 degrees of malignancy, 7 – benign neoplasms (meningiomas), 4 – control (conditionally healthy donors).Results. During the primary analysis, a pool of 71 differentially expressed microRNAs was identified, the expression of which was tumor-specific: 20 microRNAs for glioblastoma, 4 microRNAs for astrocytoma, 23 microRNAs for oligodendroglioma, 24 microRNAs for meningioma. At the same time, 47 microRNAs showed increased levels in the blood plasma compared to the control group, 15 showed a corresponding decrease in levels. A comparative analysis identified microRNAs that specifically differentiate each tumor type.Conclusion. The results obtained seem promising and set the vector for further research, which will include expanding the sample and validating the identified biomarkers to determine their diagnostic value.
format Article
id doaj-art-3d8bbed8ff304932ab34b2878491f63c
institution Kabale University
issn 2410-1893
language Russian
publishDate 2024-06-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-3d8bbed8ff304932ab34b2878491f63c2025-02-03T07:12:18ZrusQUASAR, LLCИсследования и практика в медицине2410-18932024-06-01112364510.17709/2410-1893-2024-11-2-3537Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomasD. Yu. Gvaldin0N. A. Petrusenko1E. E. Rostorguev2S. N. Dimitriadi3S. E. Kavitskiy4N. N. Timoshkina5National Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationNational Medical Research Centre for Oncology<p> Rostov-on-Don, Russian FederationAgainst the background of modest successes in the development of new diagnostic and therapeutic tools to improve the survival of patients with glial brain tumors, early diagnosis of this pathology remains relevant. Endogenous noncoding miRNAs that regulate the expression of target mRNAs have become attractive targets for the development of circulating biomarker-based assays, because sample acquisition does not require invasive sampling such as biopsy.Purpose of the study. To determine the levels of circulating microRNAs in the blood plasma of patients with glial tumors, meningiomas and apparently healthy donors, using high-output sequencing.Material and methods. 26 blood plasma samples were selected from the biobank data base of the National Medical Research Center for Oncology, and the total RNA was studied using the NGS sequencing method. The sample included: 2 cases of oligodendroglioma (grades 2–3), 6 – astrocytomas of 2–4 degrees of malignancy, 7 – glioblastomas of 4 degrees of malignancy, 7 – benign neoplasms (meningiomas), 4 – control (conditionally healthy donors).Results. During the primary analysis, a pool of 71 differentially expressed microRNAs was identified, the expression of which was tumor-specific: 20 microRNAs for glioblastoma, 4 microRNAs for astrocytoma, 23 microRNAs for oligodendroglioma, 24 microRNAs for meningioma. At the same time, 47 microRNAs showed increased levels in the blood plasma compared to the control group, 15 showed a corresponding decrease in levels. A comparative analysis identified microRNAs that specifically differentiate each tumor type.Conclusion. The results obtained seem promising and set the vector for further research, which will include expanding the sample and validating the identified biomarkers to determine their diagnostic value.https://www.rpmj.ru/rpmj/article/view/989micrornagliomasmeningiomashigh-output sequencingcirculating biomarkers
spellingShingle D. Yu. Gvaldin
N. A. Petrusenko
E. E. Rostorguev
S. N. Dimitriadi
S. E. Kavitskiy
N. N. Timoshkina
Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
Исследования и практика в медицине
microrna
gliomas
meningiomas
high-output sequencing
circulating biomarkers
title Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
title_full Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
title_fullStr Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
title_full_unstemmed Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
title_short Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
title_sort comparative analysis of the profile of circulating micrornas in the blood plasma of patients with gliomas
topic microrna
gliomas
meningiomas
high-output sequencing
circulating biomarkers
url https://www.rpmj.ru/rpmj/article/view/989
work_keys_str_mv AT dyugvaldin comparativeanalysisoftheprofileofcirculatingmicrornasinthebloodplasmaofpatientswithgliomas
AT napetrusenko comparativeanalysisoftheprofileofcirculatingmicrornasinthebloodplasmaofpatientswithgliomas
AT eerostorguev comparativeanalysisoftheprofileofcirculatingmicrornasinthebloodplasmaofpatientswithgliomas
AT sndimitriadi comparativeanalysisoftheprofileofcirculatingmicrornasinthebloodplasmaofpatientswithgliomas
AT sekavitskiy comparativeanalysisoftheprofileofcirculatingmicrornasinthebloodplasmaofpatientswithgliomas
AT nntimoshkina comparativeanalysisoftheprofileofcirculatingmicrornasinthebloodplasmaofpatientswithgliomas